US Stock Market Move | Weight loss drug concept stocks are strong, with Suodi Biotech (GPCR.US) rising more than 5%.
US weight loss pill concept stocks strengthen, as of the time of writing, Shuodi Bioscience's stock is up more than 5%.
On Wednesday, the concept stocks of weight loss drugs in the US stock market performed well. As of the deadline, Shodex Biotechnology (GPCR.US) rose by over 5%, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rose by over 3.5%, Roche (RHHBY.US) rose by over 3%, and Eli Lilly (LLY.US) rose slightly. In terms of news, Shodex Biotechnology previously announced positive top-line results for its once-daily, orally administered small molecule GLP-1 receptor agonist aleniglipron in the ACCESS clinical trial.
Related Articles
US Stock Market Move | SpaceX is preparing for an epic IPO. Destiny Tech100 (DXYZ.US) rose nearly 12%.
US Stock Market Move | The fourth-quarter financial report exceeded expectations, and Photronics, Inc. (PLAB.US) surged nearly 48% in early trading.
US Stock Market Move | Warner Brothers Exploration (WBD.US) rose nearly 4%, surging 150% since September.
US Stock Market Move | SpaceX is preparing for an epic IPO. Destiny Tech100 (DXYZ.US) rose nearly 12%.
US Stock Market Move | The fourth-quarter financial report exceeded expectations, and Photronics, Inc. (PLAB.US) surged nearly 48% in early trading.
US Stock Market Move | Warner Brothers Exploration (WBD.US) rose nearly 4%, surging 150% since September.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
